David Hallal

David Hallal is CEO, Chairman, and Co-Founder at ElevateBio, as well as CEO and Chairman at AlloVir, and ElevateBio company. He is also Chairman of the Board of Directors at the biotechnology companies iTeos Therapeutics and Scholar Rock. Prior to his roles at iTeos and Scholar Rock, David was Chief Executive Officer of Alexion Pharmaceuticals, which he first joined in 2006. In addition to his CEO role, David also served as a Board member, Chief Operating Officer, Chief Commercial Officer, and Head of Commercial Operations. Before joining Alexion, David served as Vice President of Sales for OSI Eyetech from 2004 to 2006. He served as Head of Sales at Biogen from 2002 to 2004, and before that, he was in a variety of leadership roles at Amgen from 1992 to 2002. David began his pharmaceutical career at The Upjohn Company, where he was a sales representative from 1998 to 1992. He has a B.A. in psychology from the University of New Hampshire.